These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 1614535)

  • 21. Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP.
    Monfar M; Lemon KP; Grammer TC; Cheatham L; Chung J; Vlahos CJ; Blenis J
    Mol Cell Biol; 1995 Jan; 15(1):326-37. PubMed ID: 7528328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure of rapamycin to block proliferation once resting cells have entered the cell cycle despite inactivation of p70 S6 kinase.
    Terada N; Franklin RA; Lucas JJ; Blenis J; Gelfand EW
    J Biol Chem; 1993 Jun; 268(16):12062-8. PubMed ID: 8389370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapamycin inhibits the phosphorylation of p70 S6 kinase in IL-2 and mitogen-activated human T cells.
    Terada N; Lucas JJ; Szepesi A; Franklin RA; Takase K; Gelfand EW
    Biochem Biophys Res Commun; 1992 Aug; 186(3):1315-21. PubMed ID: 1380801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapamycin inhibits p34cdc2 expression and arrests T lymphocyte proliferation at the G1/S transition.
    Flanagan WM; Crabtree GR
    Ann N Y Acad Sci; 1993 Nov; 696():31-7. PubMed ID: 8109837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells.
    Wiederrecht GJ; Sabers CJ; Brunn GJ; Martin MM; Dumont FJ; Abraham RT
    Prog Cell Cycle Res; 1995; 1():53-71. PubMed ID: 9552353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of the immunophilin ligands rapamycin and FK506 on proliferation of mast cells and other hematopoietic cell lines.
    Hultsch T; Martin R; Hohman RJ
    Mol Biol Cell; 1992 Sep; 3(9):981-7. PubMed ID: 1384815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uncoupling p70(s6) kinase activation and proliferation: rapamycin-resistant proliferation of human CD8(+) T lymphocytes.
    Slavik JM; Lim DG; Burakoff SJ; Hafler DA
    J Immunol; 2001 Mar; 166(5):3201-9. PubMed ID: 11207273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells.
    Marx SO; Jayaraman T; Go LO; Marks AR
    Circ Res; 1995 Mar; 76(3):412-7. PubMed ID: 7532117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapamycin-FKBP12 blocks proliferation, induces differentiation, and inhibits cdc2 kinase activity in a myogenic cell line.
    Jayaraman T; Marks AR
    J Biol Chem; 1993 Dec; 268(34):25385-8. PubMed ID: 7503980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the Mr 70,000 S6 kinase pathway by rapamycin results in chromosome malsegregation in yeast and mammalian cells.
    Bonatti S; Simili M; Galli A; Bagnato P; Pigullo S; Schiestl RH; Abbondandolo A
    Chromosoma; 1998 Dec; 107(6-7):498-506. PubMed ID: 9914383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of microtubule-associated protein kinase (Erk) and p70 S6 kinase by D2 dopamine receptors.
    Welsh GI; Hall DA; Warnes A; Strange PG; Proud CG
    J Neurochem; 1998 May; 70(5):2139-46. PubMed ID: 9572301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct pathways involving the FK506-binding proteins 12 and 12.6 underlie IL-2-versus IL-15-mediated proliferation of T cells.
    Dubois S; Shou W; Haneline LS; Fleischer S; Waldmann TA; Müller JR
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14169-74. PubMed ID: 14605212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunopharmacology of rapamycin.
    Abraham RT; Wiederrecht GJ
    Annu Rev Immunol; 1996; 14():483-510. PubMed ID: 8717522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An FKBP-rapamycin-sensitive, cyclin-dependent kinase activity that correlates with the FKBP-rapamycin-induced G1 arrest point in MG-63 cells.
    Albers MW; Brown EJ; Tanaka A; Williams RT; Hall FL; Schreiber SL
    Ann N Y Acad Sci; 1993 Nov; 696():54-62. PubMed ID: 8109857
    [No Abstract]   [Full Text] [Related]  

  • 35. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.
    Bierer BE; Mattila PS; Standaert RF; Herzenberg LA; Burakoff SJ; Crabtree G; Schreiber SL
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9231-5. PubMed ID: 2123553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of rapamycin on the expression of the IL-2 receptor (CD25).
    Woerly G; Brooks N; Ryffel B
    Clin Exp Immunol; 1996 Feb; 103(2):322-7. PubMed ID: 8565319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast.
    Heitman J; Movva NR; Hall MN
    Science; 1991 Aug; 253(5022):905-9. PubMed ID: 1715094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Transplantation immunology and immunosuppressive drug].
    Suzuki S
    Nihon Geka Gakkai Zasshi; 1996 Nov; 97(11):964-9. PubMed ID: 9010851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of p70/p85 S6 kinase activities in T cells by dexamethasone.
    Monfar M; Blenis J
    Mol Endocrinol; 1996 Sep; 10(9):1107-15. PubMed ID: 8885245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapamycin-induced inhibition of p34cdc2 kinase activation is associated with G1/S-phase growth arrest in T lymphocytes.
    Morice WG; Brunn GJ; Wiederrecht G; Siekierka JJ; Abraham RT
    J Biol Chem; 1993 Feb; 268(5):3734-8. PubMed ID: 8429048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.